Metformin Use May Curb BCC Risk Metformin Use May Curb BCC Risk
The decrease in basal cell carcinoma (BCC) risk was seen across all metformin dosing levels, but the reason for this remains unclear.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Dermatology News Source Type: news
More News: Basal Cell Carcinoma | Cancer & Oncology | Carcinoma | Dermatology | Fortamet | Hematology | Metformin | Skin | Skin Cancer